They are part of the 300 million people globally living with a rare disease. A disease is considered 'rare' if it affects fewer than one out of every 2,000 people.
Scientists are still developing a treatment for alternating hemiplegia of childhood, and the tests and therapy for this rare disorder cause millions of dollars.